Synthesis and properties of the antileukemic agent 5(or 4)-[3,3-bis(2-chloroethyl)-1-triazeno]imidazole-4(or 5)-carboxamide
โ Scribed by Y. Fulmer Shealy; Charles A. Krauth; Lee B. Holum; William E. Fitzgibbon
- Publisher
- John Wiley and Sons
- Year
- 1968
- Tongue
- English
- Weight
- 373 KB
- Volume
- 57
- Category
- Article
- ISSN
- 0022-3549
No coin nor oath required. For personal study only.
โฆ Synopsis
Synthesis and Properties of the Antileukemic Agent 5 ( or 4)-[ 3,3-Bis( 2-~hloroethyl)-~-triazeno]irnidazole-4( or 5)-carboxamide By Y. FULMER SHEALY, CHARLES A. KRAUTH*, LEE B. HOLUM, and WILLIAM E. FITZGIBBON The antileukemic agent 5 (or 4 ) -I 3,3 -bis (2-chloroeth yl) -1 -triazeno]imidazole-4(or 5)-carboxamide (11, NSC-82196
) is an unstable compound that is easily converti ble to an isomeric transformation product. By taking appropriate precautions, however, the triazene may be prepared in good yield, with very little of the transformation product as contaminant, and may be stored for long periods at low temperatures. The quality of specimens of I1 may be estimated from its infrared spectrum and that of its transformation product.
N THE MOUSE lymphoid leukemia L1210 test I system (l), 5(or 4)-[3,3-bis(2-chloroethyl)-1-triazeno ]imidazole-4(or 5)-carboxamide (11) has demonstrated excellent activity. Some of the animals treated with large single doses of this compound survived until the experiments were terminated 4-8 months after treatment. From
๐ SIMILAR VOLUMES
Reaction of dimethylamine 14C with a four-fold molar excess of 5-diazoimidazole-4-carboxamide in methanol followed by column chromatography of the product on basic a1 umina afforded 5-3,3-dimethyl-4C-l-triazeno)imi datole-4-carboxamide in 70-75% yield and greater than 99.9% radiochemical purity. The
## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.